Tag: Research
-
Drug Improves Survival in Metastatic Breast Cancer
A drug called palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer.
-
Disrupting Gene Transcription Elongation to Treat Cancer
Targeting cancer cells with a transcription elongation inhibitor delayed tumor progression in animal models, according to a recent Northwestern Medicine study.
-
Neural Mechanism for Error Correction in Motor Activity Uncovered
Northwestern Medicine scientists have discovered a mechanism for rapid, fine adjustments in motor plans, according to a recent study.
-
Quality of Life Holds Steady With Prostate Cancer Drug
In a recent clinical trial, a drug called apalutamide added to standard therapy slowed cancer progression in men with prostate cancer, while maintaining quality of life.
-
Another Record-Breaking Year For Northwestern Research
Northwestern’s sponsored research awards grew to $702.1 million last fiscal year, the largest amount in the University’s history and a 3.8 percent increase over the previous year’s record-breaking $676.5 million.
-
New Discovery Opens Path to Treatments for Hearing Loss
In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
-
Rising Estrogen Levels May Cause Common Men’s Hernias
A Northwestern Medicine study has demonstrated that an age-related increase in estrogen may be the culprit behind a common hernia in elderly men.
-
Addressing the Lack of Women in Orthopaedic Surgery
Linda Suleiman, MD, ’17 GME, assistant professor of Orthopaedic Surgery, discusses her recent study on the representation of women in orthopaedic surgery.
-
Alzheimer’s Drug Shows Promise, But Risk Remains
An experimental genetic inhibitor that could stave off Alzheimer’s disease has unintended consequences, but may represent a target for future drug development, according to a recent study.
-
Diabetes Drug Reduces Risk of Heart Attacks, Strokes From Air Pollution
Metformin, an inexpensive diabetes drug, has been found to reduce the risk of heart attacks and strokes triggered by air pollution by reducing inflammation in the lungs that triggers clotting.
